infecti
diseas
continu
everpres
threat
mankind
despit
medic
advanc
infecti
diseas
still
caus
death
million
around
world
estim
million
death
occur
throughout
world
year
percent
directli
caus
infecti
diseas
percent
worldwid
mortal
infecti
diseas
caus
hand
diseas
includ
lower
respiratori
infect
hivaid
diarrheal
diseas
tuberculosi
malaria
measl
figur
new
target
novel
antiinfect
drug
need
identifi
particularli
light
emerg
drug
resist
strain
mani
herbal
medicin
ethnomedicin
use
treatment
infecti
condit
respiratori
ailment
howev
research
programm
import
valid
tradit
use
provid
evid
safeti
qualiti
plant
materi
tradit
use
herbal
medicin
may
well
provid
basi
develop
modern
highli
success
phytopharmaceut
meet
intern
requir
criteria
qualiti
safeti
efficaci
evidencebas
therapi
exemplarili
shown
pelargonium
sidoid
member
genu
pelargonium
highli
valu
tradit
healer
south
african
nativ
popul
cur
palli
effect
treatment
gastrointestin
disord
interest
p
sidoid
heighten
report
therapeut
benefit
infecti
condit
respiratori
tract
tuberculosi
relat
diseas
interest
ethnobotan
commerci
histori
well
phytochem
profil
medicin
plant
review
detail
elsewher
thu
reiter
vide
infra
report
aim
review
current
knowledg
mechan
underli
benefici
effect
p
sidoid
relat
herbal
drug
prepar
notabl
special
extract
subject
clinic
studi
involv
patient
includ
children
young
year
review
repeatedli
elsewher
vide
infra
object
review
show
potenti
tradit
plant
p
sidoid
defenc
pathogen
improv
immun
function
variou
level
thu
invalu
role
natur
product
continu
play
drug
discoveri
process
area
infecti
diseas
histor
ethnomedicin
use
p
sidoid
tradit
medic
system
southern
africa
mainli
associ
gastrointestin
disord
diarrhoea
dysenteri
wherea
record
exist
treatment
respiratori
condit
tuberculosi
cough
cold
sore
throat
sourc
inform
alway
provid
context
appear
import
note
gener
problem
surround
taxonom
classif
pelargonium
speci
reflect
past
numer
revis
southern
africa
tuberculosi
one
commonli
notifi
diseas
absenc
effect
chemotherapi
earlier
day
tradit
healer
wide
consult
mani
local
plant
use
allevi
tuberculosisrel
symptom
p
sidoid
key
role
success
introduct
profound
tradit
herbal
remedi
modern
phytotherapi
europ
link
charl
henri
steven
believ
cure
take
brew
prepar
root
subsequ
tri
introduc
steven
consumpt
cure
market
great
britain
herbal
treatment
see
increas
popular
southern
africa
also
european
countri
commonwealth
independ
state
baltic
state
mexico
follow
welldocu
therapeut
benefit
infecti
condit
respiratori
tract
modern
formul
root
p
sidoid
exclus
contain
market
spitzner
arzneimittel
ettlingen
germani
elabor
tradit
herbal
medicin
special
aqueou
ethanol
extract
result
number
clinic
studi
includ
sever
randomis
doubleblind
placebocontrol
trial
support
use
respiratori
tract
infect
bronchiti
sinus
tonsil
sever
postmarket
surveil
studi
avail
demonstr
safeti
toler
trade
product
approv
germani
drug
treat
acut
bronchiti
ill
one
frequent
diagnos
medic
practic
predominantli
caus
rna
virus
less
case
nonvir
agent
play
role
etiolog
surprisingli
prescript
antibiot
infect
viral
origin
still
widespread
even
though
efficaci
limit
bacteri
infect
one
purpos
might
avoid
secondari
bacteri
superinfect
group
streptococci
develop
resist
bacteria
disadvantag
nonind
antibiot
therapi
base
clinic
studi
pelargoniumbas
prepar
offer
altern
therapeut
agent
otherwis
indic
antibiot
treatment
follow
earlier
claim
antimycobacteri
efficaci
p
sidoid
methanol
extract
root
characterist
phenol
coumarin
constitu
test
particular
biolog
activ
use
radiorespirometr
bactec
method
extract
show
antimycobacteri
activ
mycobacterium
tuberculosi
none
purifi
compound
test
exhibit
antimycobacteri
activ
experiment
condit
extract
exhibit
weak
activ
tuberculosi
mic
assess
broth
microdilut
alamar
blue
assay
rifampicin
use
refer
show
mic
experiment
condit
use
independ
support
weak
antimycobacteri
activ
p
sidoid
provid
similar
studi
aceton
ethanol
root
extract
use
tuberculosi
smegmati
test
organ
coumarin
flavonoid
isol
plant
sourc
prove
inact
mic
aqueou
aceton
extract
p
sidoid
show
neglig
antimycobacteri
activ
rapidli
grow
avirul
smegmati
broth
microdilut
assay
similar
result
obtain
test
extract
aurum
speci
report
predict
activ
tuberculosi
compar
drug
sensit
profil
find
suggest
direct
antimycobacteri
activ
appar
depend
strain
mycobacterium
also
strongli
extract
prepar
composit
cours
search
antimycobacteri
constitu
straightchain
fatti
acid
present
nhexan
root
extract
activ
panel
rapidli
grow
mycobacteria
identifi
interestingli
satur
fatti
acid
except
lauric
acid
devoid
antimycobacteri
activ
wherea
unsatur
analogu
includ
oleic
acid
linol
acid
activ
latter
potent
one
mic
aurum
howev
data
provid
convinc
evid
antimycobacteri
principl
p
sidoid
tradit
medicin
decoct
infus
use
thu
put
question
presenc
effect
level
lipophil
constitu
aqueou
prepar
furthermor
note
mycobacteria
intracellularli
resid
pathogen
vitro
protocol
conduct
reflect
direct
action
pathogen
p
sidoid
root
extract
appar
show
limit
antimycobacteri
activ
test
condit
reflect
studi
take
account
overal
moder
antimycobacteri
activ
experi
carri
far
highli
like
claim
effect
use
p
sidoid
treatment
tuberculosi
may
due
stimul
nonspecif
immun
system
rather
direct
action
mycobacteria
pathogen
antimycobacteri
principl
popular
pelargonium
speci
remain
identifi
parallel
work
focus
evalu
antibacteri
activ
p
sidoid
panel
microorgan
staphylococcu
aureu
streptococcu
pneumonia
streptococcu
escherichia
coli
klebsiella
pneumonia
proteu
mirabili
pseudomona
aeruginosa
haemophilu
influenza
associ
respiratori
diseas
howev
vitro
antibacteri
effect
aqueou
aceton
extract
fraction
obtain
thereof
success
partit
water
organ
solvent
ethyl
acet
nbutanol
mic
rang
isol
compound
mic
shown
modest
compar
classic
antibiot
note
standard
root
extract
hitherto
subject
similar
antibacteri
studi
though
moder
activ
commonli
note
independ
support
weak
direct
antibacteri
activ
follow
studi
use
liquid
prepar
isol
streptococcu
pneumonia
pyogen
viridan
staphylococcu
aureu
epidermi
neisseria
spp
moraxella
catarrhali
haemophilu
influenza
obtain
throat
cultur
patient
employ
microdilut
broth
method
mic
valu
rang
mic
bacteria
test
disappoint
find
prompt
seri
studi
attempt
demonstr
indirect
antibacteri
mechan
could
provid
clue
antiinfect
properti
p
sidoidesbas
herbal
medicin
adhes
pathogen
bacteria
host
cell
surfac
crucial
event
colon
infect
inhibit
microbi
dock
process
epitheli
cell
earli
stage
would
effect
protect
host
cell
infect
use
fluorescentlabel
group
astreptococci
viabl
human
laryng
cell
model
flow
cytometr
measur
show
promin
ca
compar
untreat
cell
antiadhes
antiinvas
capabl
concentr
depend
manner
notabl
inhibit
streptococc
adhes
host
cell
evid
bacteria
pretreat
indic
interact
antiadhes
principl
occur
bacteri
outer
memban
surfac
bind
side
epitheli
surfac
recent
experi
reveal
proanthocyanidin
figur
play
decis
role
observ
inhibit
group
astreptococci
dock
process
cell
conclud
appar
miss
activ
phenolicfre
extract
pictur
emerg
antiadhes
studi
includ
homogen
epicatechin
catechinbas
polyflavan
mix
procyanidin
sampl
prodelphinidin
test
substanc
well
atyp
proanthocyanidin
provid
evid
antistreptococc
activ
polyphenol
appear
due
prodelphinidintyp
substructur
epigallocatechin
gallocatechin
extend
unit
pretreat
experi
indic
interact
antiadhes
proanthocyanidin
occur
bind
factor
bacteri
surfac
block
molecul
exampl
fibronectin
collagenbind
adhes
remain
identifi
interestingli
bacteri
attach
enhanc
ca
influenc
use
buccal
epitheli
cell
notic
mostli
dead
inactiv
trap
microorgan
may
explain
fact
decay
buccal
cell
physiolog
slough
swallow
saliva
way
intercept
pathogen
avail
adhes
intact
cell
take
account
fairli
high
inhibit
bacteri
adhes
viabl
epitheli
cell
indirect
antibacteri
activ
benefici
effect
infecti
condit
impact
microbi
adhes
also
demonstr
studi
helicobact
pylori
pretreat
fluorescentlabel
h
pylori
p
sidoid
extract
inhibit
adher
human
gastric
mucosa
cell
dosedepend
manner
howev
underli
biolog
activ
principl
remain
identifi
taken
togeth
demonstr
antiadhes
mechan
may
well
contribut
antiinfect
activ
earli
time
point
bacteri
infect
also
worthi
mention
potenti
p
sidoid
extract
significantli
inhibit
streptococc
invas
cell
similarli
antiadhes
activ
polyphenol
may
interfer
extracellular
protein
produc
bacteria
facilit
invas
clearli
studi
need
get
insight
underli
principl
bacteria
employ
invad
cell
medicin
viewpoint
inhibit
bacteri
invas
epitheli
cell
protect
host
pathogen
evad
host
defenc
antibiot
therapi
insid
host
cell
recurr
streptococc
infect
may
well
occur
demonstr
inhibit
streptococc
invas
thu
prevent
recurr
infect
although
find
provid
evid
direct
indirect
antibacteri
properti
p
sidoid
pronounc
antiinfect
capabl
herbal
medicin
adequ
explain
mere
basi
observ
antibacteri
activ
mucociliari
system
repres
defenc
mechan
nasal
caviti
bronchial
tree
clean
air
bacteria
foreign
particl
ciliari
beat
frequenc
cbf
import
paramet
determin
efficaci
significantli
concentrationdepend
increas
cbf
adher
monolay
cultur
human
nasal
epithelium
cell
increas
ca
compar
equilibrium
phase
wash
procedur
cbf
return
equilibr
period
howev
subsequ
examin
prove
effect
vivo
condit
emphasi
mucociliari
clearanc
sinc
respiratori
tract
infect
frequent
caus
virus
case
noteworthi
exhibit
antivir
effect
number
assay
exampl
promin
cytoprotect
effect
observ
fibroblastviru
protect
assay
test
model
supernat
activ
macrophag
transfer
monolay
encephalomyocard
viru
emcv
ifnsensit
murin
l
fibroblast
exposur
emcv
suspens
ifn
activ
assess
observ
protect
cytopath
effect
cpe
induc
infect
emcv
rel
number
viabl
cell
determin
spectrophotometr
use
crystal
violet
stain
reagent
protect
cell
antivir
protect
express
uml
defin
reciproc
valu
supernat
dilut
would
inhibit
cpe
induc
emcv
valu
correl
ifn
standard
uml
account
fluctuat
assay
sensit
promin
cytoprotect
effect
ca
observ
remark
low
dose
complet
inhibit
cpe
sampl
concentr
recent
refin
work
show
supernat
bone
marrowderiv
macrophag
stimul
produc
antivir
activ
ca
uml
similar
lp
ngml
respons
known
antivir
factor
member
ifn
famili
classifi
type
type
ii
interferon
accord
receptor
specif
sequenc
homolog
sinc
function
assay
discrimin
author
interest
focus
detect
use
elisa
attempt
identifi
potenti
antivir
compound
unsuccess
suggest
either
product
effect
ifn
level
detect
limit
assay
synergist
effect
may
contribut
power
overal
action
element
immun
system
type
iii
ifn
respons
effect
agent
eicosanoid
may
play
role
control
viral
infect
may
exclud
shown
suppress
product
calciumionophor
stimul
human
granulocyt
previou
studi
rang
proanthocyanidin
indic
member
class
compound
possess
pronounc
ifnlik
activ
presenc
extract
may
also
induc
factor
worthi
mention
extract
induc
cytoprotect
effect
directli
expos
clearli
indic
indirect
mode
action
note
known
antivir
factor
member
ifn
famili
appar
modulatori
potenc
ifn
level
endow
potent
antivir
effect
mediat
function
activ
natur
killer
cell
demonstr
enhanc
synthesi
human
osteosarcoma
cell
superinduc
viral
doublestrand
rna
analogu
polyinosin
acid
polycytidyl
acid
effect
evid
presenc
infecti
compon
maximum
augment
applic
remark
select
signific
activ
nonspecif
immun
system
come
forc
invas
pathogen
direct
antivir
activ
p
sidoid
aqueou
extract
first
evalu
vitro
herp
simplex
viru
type
type
cell
use
plaqu
reduct
assay
herp
virus
caus
common
infect
recurr
orofaci
genit
lesion
pretreat
virus
extract
subsequ
infect
cell
reveal
pronounc
antivir
effect
concentrationdepend
manner
valu
respect
take
account
excel
select
index
defin
ratio
valu
cytotox
cell
mgml
antiherp
activ
antivir
effect
like
due
interact
viru
extract
compon
howev
remain
identifi
notabl
maxim
noncytotox
sampl
concentr
plaqu
format
reduc
ca
mode
action
investig
set
experi
incub
adsorpt
replic
period
viru
result
show
addit
extract
exclus
adsorpt
period
hsv
significantli
reduc
infect
polyphenol
may
repres
underli
activ
principl
act
select
rather
nonspecif
manner
follow
therapeut
use
modern
phytomedicin
treatment
upper
respiratori
tract
infect
demonstr
antivir
effect
extract
panel
virus
includ
season
influenza
viru
strain
respiratori
syncyti
viru
human
coronaviru
parainfluenza
viru
coxsacki
viru
provid
evid
feasibl
benefici
effect
patient
suffer
acut
bronchiti
relat
infecti
diseas
except
coxsacki
sensit
virus
envelop
suggest
inhibit
prefer
replic
virus
categori
line
potenti
antivir
effect
envelop
herp
virus
fact
show
influenc
nonenvelop
rhino
adenovirusesinduc
cytopathogen
effect
observ
vari
suscept
influenza
subtyp
ration
mutant
haemagglutinin
present
surfac
individu
influenza
virus
structur
modifi
glycoprotein
respons
bind
viru
host
cell
may
therefor
differ
affect
extract
experi
evalu
influenc
virusinduc
cytopathogen
effect
rang
cell
line
indic
valu
enzym
neuraminidas
sialidas
highli
conserv
activ
site
play
key
role
releas
virion
infect
host
cell
also
movement
upper
respiratori
tract
among
therapeut
option
treatment
prevent
influenza
infect
neuraminidas
inhibitor
promis
candid
inhibit
spread
viral
infect
view
claim
antivir
potenti
relat
common
cold
origin
test
vitro
neuraminidas
inhibit
activ
use
fluorometricbas
assay
compar
zanamivir
extract
exhibit
pronounc
inhibitori
activ
bacteri
neuraminidas
vibrio
cholera
valu
evid
howev
similar
inhibit
activ
viral
neuraminidas
vitro
model
demand
investig
even
interest
treatment
extract
skin
powder
remov
tannin
produc
inact
sampl
loss
activ
polyphenolfre
extract
clearli
indic
proanthocyanidin
appar
repres
underli
activ
principl
specif
polyphenol
biolog
activ
demonstr
test
rang
proanthocyanidin
sampl
compris
differ
flavanyl
constitu
unit
procyanidin
prodelphinidin
atyp
proanthocyanidin
data
suggest
neuraminidas
inhibit
activ
may
relat
prodelphinidin
extend
unit
oligoflavanoid
independ
support
antivir
activ
origin
current
studi
use
influenza
strain
oseltamivirresist
subtyp
data
suggest
inhibit
key
protein
haemagglutinin
neuraminidas
present
surfac
influenza
viru
potenc
also
evid
vivo
experi
viru
consid
interact
constitu
two
surfac
glycoprotein
import
viral
replic
lifecycl
earli
final
stage
infect
therapeut
benefit
extract
may
well
seen
light
infect
prophylaxi
improv
infecti
condit
understand
mani
effect
p
sidoid
nonspecif
immun
system
potenti
role
host
respons
pathogen
seem
appropri
illustr
key
compon
involv
clear
microbi
agent
sinc
sever
immunolog
factor
associ
antiinfect
respons
paramet
briefli
describ
primarili
impli
stimul
nonspecif
immun
system
close
relat
hitherto
known
antiinfect
principl
detect
p
sidoid
base
medicin
simplifi
overview
induc
cytotox
defenc
mechan
shown
figur
macrophag
extrem
versatil
cell
involv
number
complex
process
immun
respons
activ
acquir
microbicid
effector
function
secret
cytokin
result
recruit
immun
cell
subsequ
elimin
pathogen
phagocytosi
releas
reactiv
oxygen
nitrogen
speci
gener
reactiv
oxygen
speci
initi
nadph
oxidas
primari
product
superoxid
convert
superoxid
dismutas
subsequ
hydroxyl
radic
anion
product
nitric
oxid
mani
congen
anoth
key
macrophag
antimicrobi
respons
import
intra
intercellular
regulatori
molecul
multipl
biolog
function
includ
macrophagemedi
cytotox
endogen
deriv
gener
enzymat
larginin
constitut
c
induc
nitric
oxid
synthas
no
present
differ
cell
type
releas
constantli
physiolog
level
influenc
cno
synthas
convert
larginin
molecular
oxygen
lcitrullin
howev
express
ino
activ
macrophag
respons
immunolog
stimuli
induc
releas
larg
amount
long
period
although
speci
function
benefici
antimicrobi
effector
molecul
immun
protect
bacteria
parasit
virus
regul
cell
surviv
rel
high
sustain
level
induc
produc
immun
respons
may
harm
dramat
shown
septic
shock
accordingli
regul
product
import
human
health
presenc
superoxid
anion
seri
effector
molecul
might
prevail
also
involv
host
defenc
mechan
although
product
reactiv
oxygen
nitrogen
speci
consider
contribut
kill
infecti
pathogen
secret
cytokin
activ
macrophag
relat
cell
also
integr
compon
effect
immun
respons
viral
bacteri
infect
regulatori
function
product
cytotox
effector
speci
act
level
immun
respons
form
complex
network
molecul
among
macrophageassoci
cytokin
releas
tumour
necrosi
factor
tnf
essenti
earli
step
signal
cascad
lead
product
antimicrobi
also
synerg
induct
ino
product
macrophag
though
alon
shown
capabl
independ
enhanc
ino
transcript
releas
role
cytokin
play
nomedi
destruct
microbi
pathogen
prompt
begin
explor
pelargoniuminduc
immun
modulatori
effect
macrophag
function
use
function
assay
fibroblastlysi
assay
releas
tnf
cytopath
effect
inhibit
assay
ifnlik
properti
vide
infra
importantli
control
virus
achiev
produc
host
cell
mediat
macrophag
activ
phagocytosi
relat
activ
phagocyt
play
crucial
role
innat
immun
host
defenc
invad
pathogen
includ
bacteria
virus
circul
blood
phagocyt
rapidli
recruit
site
infect
activ
attach
pathogenassoci
molecular
pattern
microorgan
ingest
phagocyt
phagocytosi
follow
product
releas
reactiv
oxygen
speci
oxid
burst
contribut
destruct
pathogen
intracellular
kill
use
whole
bloodbas
flow
cytometr
assay
candida
albican
target
organ
significantli
increas
number
phagocytos
cell
maxim
enhanc
min
upon
addit
extract
sampl
concentrationdepend
manner
target
effector
cell
ratio
yeast
cell
ingest
min
oxid
burst
applic
extract
similarli
led
mark
increas
burstact
blood
phagocyt
time
point
observ
beyond
min
maximum
augment
min
compar
control
stimul
burst
activ
still
detect
even
candida
organ
alreadi
ingest
although
phagocyt
activ
may
strongli
depend
kind
microorgan
find
clearli
demonstr
pelargonium
extract
effect
improv
phagocyt
activ
furthermor
result
microbiolog
intracellular
kill
assay
indic
number
surviv
yeast
cell
reduc
ca
min
compar
control
benefit
oral
applic
may
seen
local
effect
resid
invad
phagocyt
site
infect
experiment
infect
macrophag
constitut
particularli
versatil
model
assess
immunoregul
occur
cellmedi
respons
intracellular
pathogen
consist
previou
antitubercular
usag
p
sidoid
tradit
medicin
safeti
reason
conveni
establish
vitro
model
infecti
diseas
select
murin
macrophag
infect
oblig
intracellular
leishmania
parasit
rather
pathogen
mycobacteria
strain
colorimetr
assay
use
assess
activ
macrophag
intracellular
parasit
base
infect
macrophag
suspens
cultur
exposur
pelargonium
extract
lysi
host
cell
sodium
dodecyl
sulfat
sd
surviv
leishmania
organ
quantit
convers
yellow
bromid
mtt
blue
formazan
product
pelargonium
extract
includ
parent
aqueou
aceton
methanol
extract
well
organ
fraction
petroleum
ether
ethyl
acet
nbutanol
prove
inact
extracellular
promastigot
form
leishmania
speci
pronounc
antileishmani
effect
observ
intracellular
amastigot
clinic
pharmacolog
import
valu
rang
compar
posit
control
confirmatori
evid
recent
provid
fluoresc
activ
cell
scan
fac
analysi
use
transgen
l
major
express
green
fluoresc
protein
gfp
method
signific
advantag
involv
count
parasit
microscop
prepar
sd
lysismtt
protocol
treatment
infect
result
signific
decreas
intracellular
gfp
signal
dose
depend
manner
reaffirm
previou
result
concern
activ
immun
defenc
mechan
singl
cell
level
figur
reduct
parasit
load
due
gener
cytotox
follow
addit
propidium
iodid
fac
measur
order
discrimin
dead
piposit
cell
experi
live
cell
exposur
infect
cell
combin
markedli
enhanc
effect
exampl
combin
plu
uml
almost
effect
uml
plu
lp
ngml
kill
intracellular
parasit
given
crucial
role
cytotox
effector
molecul
vide
supra
induc
potenti
pelargonium
extract
constitu
determin
use
supernat
sampl
treat
macrophag
raw
cultur
sourc
secret
quantit
determin
nitrit
concentr
use
griess
assay
immun
respons
consider
express
infect
cell
suggest
effect
stimul
nonspecif
immun
system
need
compar
posit
control
uml
ngml
lp
induc
potenti
hydrophil
pelargonium
extract
significantli
less
promin
howev
note
induc
product
strongli
depend
kind
macrophag
raw
use
experiment
model
inhibit
ino
addit
lnmma
produc
significantli
lower
level
concomitantli
increas
gfp
signal
provid
strong
evid
crucial
role
toxic
effector
molecul
host
defenc
microbi
infect
pronounc
noinduc
capabl
although
strong
invers
correl
product
parasit
kill
observ
involv
addit
noindepend
defenc
mechan
rule
promis
result
prompt
studi
addit
infect
model
use
intracellular
listeria
monocytogen
bacteria
motiv
pursuit
relev
studi
cellular
molecular
level
experiment
infect
model
also
commonli
use
studi
antimicrobi
defenc
consist
leishmania
model
exposur
infect
cell
significantli
enhanc
product
concentr
depend
manner
compar
infect
cell
conspicu
product
alreadi
increas
earli
time
point
post
infect
h
although
surviv
rate
measur
facsbas
assay
due
nonavail
label
l
monocytogen
organ
effici
elimin
invad
pathogen
may
anticip
data
suggest
induc
releas
broad
spectrum
infecti
condit
importantli
therapeut
relev
dose
accordingli
stimul
nonspecif
immun
system
may
anticip
intracellular
resid
mycobacteria
although
still
remain
demonstr
present
data
provid
clue
claim
efficaci
herbal
medicin
earlier
treatment
tuberculosi
relat
diseas
tradit
medicin
interestingli
test
macrophag
mammalian
host
cell
control
sampl
reveal
moder
cytotox
macrophag
activ
usual
polyphenotyp
event
tnf
releas
earli
respons
infect
measur
tnfactiv
induc
mention
pelargonium
extract
therefor
anoth
import
immunolog
paramet
evalu
antiinfect
potenti
herbal
medicin
initi
tnfreleas
assess
function
assay
tnfsensit
treat
supernat
sampleactiv
rapidli
lyse
presenc
surviv
cell
incorpor
crystal
violet
dye
rel
number
spectrophotometr
determin
concentr
ethyl
acet
ca
uml
nbutanol
phase
ca
uml
found
possess
moder
tnfinduc
potenti
remain
sampl
show
neglig
effect
uml
compar
lp
stimulu
ngml
uml
posit
control
mind
system
tnf
fatal
moder
tnfinduc
capabl
pelargonium
extract
noninfect
cell
may
benefici
function
bioassay
hitherto
extend
infect
macrophag
howev
gene
express
analysi
clearli
show
augment
prolong
upregul
tnf
transcript
infect
cell
vide
supra
confirmatori
evid
increas
intracellular
tnf
level
induc
infecti
condit
compar
noninfect
cell
recent
obtain
fac
analysi
singl
cell
level
conspicu
accumul
membranebound
cytokin
stimul
infect
cell
ca
less
pronounc
untreat
cultur
ca
phenomenon
may
explain
enhanc
activ
convert
enzym
mediat
herbal
extract
conjectur
found
support
increas
solubl
protein
level
detect
elisa
supernat
infect
cell
treat
titer
ca
ngml
test
concentr
conspicu
posit
lp
control
infect
cell
ca
ngml
case
besid
earli
macrophageassoci
cytokin
product
includ
interleukin
il
analys
intracellularmembranebound
cytokin
carri
parallel
noninfect
infect
cell
absenc
presenc
respect
singl
cell
level
use
flow
cytometri
elisa
use
monitor
secret
cytokin
cell
supernat
use
experiment
infect
l
monocytogen
incub
increas
product
intra
extracellular
compar
noninfect
infect
cell
demonstr
augment
product
confirm
potenti
induc
host
defenc
mechan
control
infecti
agent
singl
cell
level
known
synerg
induct
product
turn
induc
releas
nk
cell
cell
turn
mediat
protect
induc
product
also
import
matur
demonstr
thu
provid
link
innat
adapt
immun
induct
protect
immun
leishmania
infect
pathogen
agent
close
link
product
cytokin
analysi
data
obtain
densitometr
measur
reveal
ino
cytokin
mrna
level
infect
raw
cell
significantli
enhanc
respons
lp
plu
compar
noninfect
cell
notabl
produc
similar
transcript
profil
consider
increas
prolong
upregul
distinctli
express
infecti
condit
figur
transcript
cytokin
associ
downregulatori
function
clearli
express
later
find
independ
support
antiinfect
potenti
p
sidoid
observ
function
level
vide
supra
interestingli
herbal
medicin
also
stimul
infect
cell
produc
transcript
express
cell
monocyt
lineag
mere
note
certain
physiolog
patholog
condit
also
worthi
mention
upregul
mrna
level
cytokin
critic
host
defenc
varieti
pathogen
involv
product
subsequ
studi
suggest
mrna
express
appear
uniqu
featur
p
sidoid
among
herbal
extract
gene
express
experi
thu
provid
evid
macrophag
activ
transcript
level
recent
surfac
marker
becam
focu
research
interest
member
tnf
receptor
superfamili
express
primarili
antigen
present
cell
includ
macrophag
surfac
marker
found
import
regulatori
receptor
depend
independ
host
defenc
mechan
essenti
develop
cell
mediat
immun
respons
stimul
noninfect
listeriainfect
moder
enhanc
express
howev
suggest
herbal
medicin
may
sustain
upregul
express
infect
condit
conclud
promin
express
low
concentr
stimul
lp
result
dramat
downregul
receptor
subunit
h
post
infect
may
ration
internalis
receptor
downregul
receptor
infecti
condit
consist
similar
effect
l
monocytogen
infect
chang
express
suggest
affect
sensit
cell
respond
limit
molecular
studi
allow
definit
statement
least
provid
encourag
studi
p
sidoid
extract
mode
action
antiinfect
assay
polymorphonuclear
neutrophil
pmn
play
key
role
frontlin
defenc
pathogen
addit
recruit
activ
immun
cell
pmn
demonstr
releas
solubl
peptid
broadspectrum
antimicrobi
activ
bactericidalpermeabilityincreas
protein
bpi
defensin
human
neutrophil
peptid
hnp
recent
shown
enhanc
releas
antimicrobi
peptid
concentrationdepend
manner
increas
level
hnp
bpi
respect
note
extract
much
better
induc
releas
defensin
lp
ngml
wherea
lp
prove
effect
bpi
interestingli
combin
stimuli
enhanc
releas
studi
antimicrobi
peptid
disproportion
bpi
hnp
respect
find
provid
evid
immun
system
react
faster
like
effect
pathogen
treatment
absenc
herbal
medicin
tradit
south
african
herbal
medicin
use
centuri
empir
treatment
respiratori
tract
diseas
found
way
european
laboratori
recent
chemic
pharmacolog
clinic
studi
special
extract
refer
develop
tradit
medicin
prove
efficaci
condit
studi
herb
p
sidoid
effect
nonspecif
immun
system
may
lead
identif
novel
chemic
structur
newer
therapeut
agent
deriv
provid
addit
insight
mode
action
molecular
level
exampl
provid
compel
argument
continu
explor
natur
tradit
medic
system
sourc
therapeut
use
herbal
medicin
satisfi
current
criteria
qualiti
safeti
efficaci
evidencebas
therapi
